We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3626:TSETIS Inc. Analysis

Data as of 2026-03-12 - not real-time

¥3,366.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at 3,366 JPY, well below its 20‑day (3,184) and 50‑day (4,094) simple moving averages, confirming a bearish price trend despite a bullish MACD histogram that suggests short‑term momentum may be turning positive. RSI sits at 44, indicating the price is not yet oversold, while the 30‑day volatility exceeds 68%, reflecting a highly volatile environment. The beta of roughly 0.42 points to limited systematic risk, yet the price remains confined between a support level of 2,892.5 JPY and resistance near 3,547 JPY, leaving limited upside in the immediate term.
Fundamentally, the company appears undervalued with a trailing P/E of 14.7 versus an industry average of 34.6, a price‑to‑book of 2.29, and a dividend yield of 2.27% supported by a modest 32% payout ratio. Analyst consensus targets (median 4,675 JPY) imply a potential upside of over 30%, and the increasing volume trend adds a layer of liquidity confidence. Nonetheless, zero revenue growth and a high historical drawdown of 45% temper enthusiasm, suggesting investors should weigh the value appeal against the pronounced price volatility.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below short‑term moving averages
  • Bullish MACD signal amidst high volatility
  • Proximity to near‑term resistance level

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation gap to industry peers
  • Attractive dividend yield with sustainable payout
  • Analyst price targets indicating >30% upside

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Stable cash position and low leverage
  • Consistent profitability margins
  • Low beta and defensive sector positioning

Key Metrics & Analysis

Financial Health

Profit Margin9.09%
P/E Ratio14.7
ROE16.34%
ROA8.96%
Debt/Equity11.71
P/B Ratio2.3
Industry P/E34.6

Technical Analysis

TrendBearish
RSI44.1
Support¥2,892.50
Resistance¥3,547.00
MA 20¥3,184.40
MA 50¥4,093.68
MA 200¥4,713.73
MACDBullish
VolumeIncreasing
Fear & Greed Index78.16

Valuation

Target Price¥4,514.00
Upside/Downside34.11%
GradeUndervalued
TypeValue
Dividend Yield2.27%

Risk Assessment

Beta0.42
Volatility68.48%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.